ArticleFrontiers in oncology2026

Lisaftoclax combined with ixazomib and dexamethasone after CAR-T for maintenance therapy in transplant-ineligible relapsed/refractory ultra-high-risk multiple myeloma: two case reports and literature review.

Weige Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.